SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] - N0000193948

Pharmacologic Code	N0000193948
Pharmacologic Name	SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor
Pharmacologic Uses	SARS-CoV-2 nucleotide analog RNA polymerase inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 2 products whose active ingredient are classified under the same pharmacologic class SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	61958-2901	Veklury	Non-Proprietary Name: Remdesivir	Injection, Powder, Lyophilized, For Solution	Intravenous	Gilead Sciences, Inc.	ACTIVE
	61958-2902	Veklury	Non-Proprietary Name: Remdesivir	Injection	Intravenous	Gilead Sciences, Inc.	ACTIVE